Holen Sie sich die Stockscreener-App
25.51
0.47%
0.1186
Handel nachbörslich:
25.62
0.11
+0.43%
Roundhill Glp 1 Weight Loss Etf Aktie (OZEM) Neueste Nachrichten
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - sg.finance.yahoo.com
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Investing in the Dip: Evaluating ETF Exposure to Eli Lilly Amid Sector Volatility and GLP-1 Growth - AInvest
Will drop go up or down throughout this week - AInvest
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
How to Invest in GLP-1 Stocks - The Motley Fool
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - The Daily Upside
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - MSN
The GLP-1 Boom: Why OZEM is Poised to Capitalize on the Obesity Drug Revolution - AInvest
Inside Last Week's Wall Street Rally & Best-Performing ETF Areas - TradingView
5 Sector ETFs Up 10% Despite February's Market Slump - TradingView
Slower flows, small-cap woes, SEC nos! What to expect from ETFs in 2025 - Citywire
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Roundhill Investments Surpasses $4 Billion AUM Milestone – Company Announcement - Financial Times
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - Yahoo Finance
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Tap the Weight-Loss Drug Market With These ETFs - Yahoo Finance
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
5 ETFs to Make the Most of Eli Lilly's Strength - Yahoo Finance
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Nasdaq
Where to Invest in Health Trends - Bloomberg.com
Top Themes in the First Half of 2024: Crypto, Chips, Ships & Silver - ETF Trends
Novo-Nordisk's "miracle weight-loss drug" has been approved domestically, waiting to explode onto the multi-billion dollar market! How to capture this wave of "weight-loss fever"? - 富途牛牛
Why Investors Haven't Feasted on Two New Weight-Loss ETFs - Investopedia
Weight-loss ETFs demand some heavy thinking - Financial Times
Wall Street issuer creates “Lucky 8” Chinese giant ETF to target the “Seven Heroes” of US stock technology - 富途牛牛
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk - TradingView
OZEM, Weight Loss Drug ETFs: Should You Invest? - ETF.com
Did South Park mark the top for weight-loss stocks? - Sherwood News
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF - InvestorPlace
This new weight loss drug ETF bets big on two of the industry's leading players - CNBC
This Week in ETFs: Roster of 17 New ETFs Includes 6 Buffer Funds - ETF Trends
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next - Benzinga
Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance
Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM) - Stock Titan
Fund Files: Eaton Vance, Voya PMs to depart; Roundhill launches active weight loss ETF - Citywire
Roundhill names new CEO - Citywire Professional Buyer
CHAT Stock Price | Roundhill Generative AI & Technology ETF - Investing.com
0.29%
0.08%
Kapitalisierung:
|
Volumen (24h):